State Street Corp Red Hill Biopharma Ltd. Transaction History

State Street Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.63 - $2.58 $105 - $430	167 Added 0.32%	52,198 $45,000
Q1 2022 May 16, 2022	BUY	$1.65 - $3.12 $4,935 - $9,331	2,991 Added 6.1%	52,031 $131,000
Q4 2021 Feb 14, 2022	BUY	$2.31 - $5.85 $4,220 - $10,687	1,827 Added 3.87%	49,040 $127,000
Q3 2021 Nov 15, 2021	SELL	$4.55 - $10.36 $283,833 - $646,267	-62,381 Reduced 56.92%	47,213 $216,000
Q2 2021 Aug 16, 2021	BUY	$5.98 - $7.51 $91,553 - $114,978	15,310 Added 16.24%	109,594 $754,000
Q1 2021 May 17, 2021	SELL	$6.98 - $11.29 $118,010 - $190,880	-16,907 Reduced 15.21%	94,284 $690,000
Q4 2020 Feb 16, 2021	BUY	$7.81 - $10.39 $74,569 - $99,203	9,548 Added 9.39%	111,191 $939,000
Q3 2020 Nov 10, 2020	BUY	$6.34 - $10.83 $568,545 - $971,191	89,676 Added 749.36%	101,643 $1.04 Million
Q2 2020 Aug 14, 2020	SELL	$4.6 - $8.6 $377,738 - $706,206	-82,117 Reduced 87.28%	11,967 $80,000
Q1 2020 May 11, 2020	BUY	$3.51 - $6.17 $330,234 - $580,498	94,084 New	94,084 $426,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.